1st Quarter - Report
STANTON PARK GROUP for BARR LABORATORIES
Firm
Client
Income
$30,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Consumer Issues/Safety/Products CSP
Generic Drug Settlements (S 316, HR 1902)
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN CAVEY | — |
| JAMES DERDERIAN | — |
| ANDREW HALATAEI | — |
| ERIN STRAWN | — |
| ASHLIE VAN METER | — |
Pharmacy PHA
Generic Biologics (HR 1956, S. 1695, HR 1038, S 623, HR 5629); FDA REform (HR 2900, S 1082) office of Generic Drugs funding in Agrigultural Approps. (HR 3161, S 1859)
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN CAVEY | — |
| JAMES DERDERIAN | — |
| ANDREW HALATAEI | — |
| ERIN STRAWN | — |
| ASHLIE VAN METER | — |
Science/Technology SCI
Patent Reform (HR 1908, S 1145)
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN CAVEY | — |
| JAMES DERDERIAN | — |
| ANDREW HALATAEI | — |
| ERIN STRAWN | — |
| ASHLIE VAN METER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.